Wilson's disease. Update of a systemic disorder with protean manifestations
- PMID: 9891702
- DOI: 10.1016/s0889-8553(05)70025-x
Wilson's disease. Update of a systemic disorder with protean manifestations
Abstract
In Wilson's disease, a genetic defect in a copper transporter causes defective incorporation of copper into apo-ceruloplasmin and the failure to excrete copper into bile. Copper accumulated in hepatocytes generates damage via reactive oxygen species. Release of copper from necrotic hepatocytes leads to damage of other tissues, including the brain, urinary tract, red blood cells, heart, endocrine glands, skin, pancreas, bones, and joints. Treatment is designed to chelate the excess copper for urinary excretion, prevent copper absorption, and render tissue copper nontoxic. Liver transplantation, with replacement of the defective hepatic gene, may be necessary in some cases.
Similar articles
-
Wilson's disease: a new gene and an animal model for an old disease.J Investig Med. 1995 Aug;43(4):323-36. J Investig Med. 1995. PMID: 7552582 Review.
-
[The onset of psychiatric disorders and Wilson's disease].Encephale. 2007 Dec;33(6):924-32. doi: 10.1016/j.encep.2006.08.009. Epub 2007 Sep 5. Encephale. 2007. PMID: 18789784 French.
-
Practical recommendations and new therapies for Wilson's disease.Drugs. 1995 Aug;50(2):240-9. doi: 10.2165/00003495-199550020-00004. Drugs. 1995. PMID: 8521757 Review.
-
New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.Biochem J. 1996 May 1;315 ( Pt 3)(Pt 3):851-5. doi: 10.1042/bj3150851. Biochem J. 1996. PMID: 8645167 Free PMC article.
-
Intracellular distribution of the Wilson's disease gene product (ATPase7B) after in vitro and in vivo exogenous expression in hepatocytes from the LEC rat, an animal model of Wilson's disease.Hepatology. 1998 Mar;27(3):799-807. doi: 10.1002/hep.510270323. Hepatology. 1998. PMID: 9500710
Cited by
-
Classification and differential diagnosis of Wilson's disease.Ann Transl Med. 2019 Apr;7(Suppl 2):S63. doi: 10.21037/atm.2019.02.07. Ann Transl Med. 2019. PMID: 31179300 Free PMC article. Review.
-
[Classification of Wilson's disease based on neurophysiological parameters].Nervenarzt. 2005 Jun;76(6):733-9. doi: 10.1007/s00115-004-1843-z. Nervenarzt. 2005. PMID: 15959750 Clinical Trial. German.
-
Activation of metallothioneins and alpha-crystallin/sHSPs in human lens epithelial cells by specific metals and the metal content of aging clear human lenses.Invest Ophthalmol Vis Sci. 2003 Feb;44(2):672-9. doi: 10.1167/iovs.02-0018. Invest Ophthalmol Vis Sci. 2003. PMID: 12556398 Free PMC article.
-
[44-year-old patient with fulminant liver failure].Internist (Berl). 2003 Oct;44(10):1301-7. doi: 10.1007/s00108-003-1016-3. Internist (Berl). 2003. PMID: 14689090 German.
-
Pyridoxal isonicotinoyl hydrazone (PIH) prevents copper-mediated in vitro free radical formation.Mol Cell Biochem. 2001 Dec;228(1-2):73-82. doi: 10.1023/a:1013348005312. Mol Cell Biochem. 2001. PMID: 11855743
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical